Person: YAMAÇ, AYLİN HATİCE
8 results
Search Results
Now showing 1 - 8 of 8
Publication Metadata only -Mitral klip vakasında, transseptal ponksiyon sırasında aortik iyatrojenik perforasyonun, amplatzer ductal occluder ile başarılı kapatılması-(2019-04-28T00:00:00Z) ENHOŞ, ASİM; KAHRAMAN AY, NURAY; ULUGANYAN, MAHMUT; BAKSHALİYEV, NİJAD; YAMAÇ, AYLİN HATİCE; ÇELİKKALE, İLKE; İSMAİLOĞLU, ZİYA; BACAKSIZ, AHMET; ÖZDEMİR, RAMAZAN; ENHOŞ, ASIM; KAHRAMAN AY, NURAY; ULUGANYAN, MAHMUT; YAMAÇ, AYLİN HATİCE; ÇELİKKALE, İLKE; BACAKSIZ, AHMET; ÖZDEMİR, RAMAZANPublication Metadata only Percutaneous closure of iatrogenic aorta right ventricular fistula(2017-10-08T00:00:00Z) ENHOŞ, ASİM; BAKSHALİYEV, NİJAD; AKDEMİR, BARIŞ; HUYUT, MUSTAFA AHMET; KARAÇÖP, ERDEM; GÖKTEKİN, ÖMER; İSMAYILOĞLU, ZİYA; NADİR, AYDIN; YAMAÇ, AYLİN HATİCE; ENHOŞ, ASIM; KARAÇÖP, ERDEM; YAMAÇ, AYLİN HATİCE; NADİR, AYDINPublication Metadata only Association between serum intermedin levels and echocardiographical measures in patients who underwent primary percutaneous coronary intervention- a six month follow up study(2014-09-26) SEVGİLİ, EMRAH; BACAKSIZ, AHMET; YAMAÇ, AYLİN HATİCE; ERCAN, ÇİLEM; BACAKSIZ, AHMET; YAMAÇ, AYLİN HATİCE; ERCAN, ÇİLEMPublication Metadata only PERIFERIK MÜDAHALEDE B PLANI! BAŞARIYA ULAŞMAK IÇIN IKINCI SEÇENEK VAR MI? VAKA SUNUMU(2018-09-23T00:00:00Z) HUYUT, MUSTAFA AHMET; YAMAÇ, AYLİN HATİCE; ENHOŞ, ASİM; KARAÇÖP, ERDEM; İSMAYILOĞLU, ZİYA; BACAKSIZ, AHMET; YAMAÇ, AYLİN HATİCE; ENHOŞ, ASIM; KARAÇÖP, ERDEM; BACAKSIZ, AHMETPublication Metadata only Can coronary guidewire save the peripheral day?(2018-10-23T00:00:00Z) HUYUT, MUSTAFA AHMET; YAMAÇ, AYLİN HATİCE; Karaçöp, Erdem; ENHOŞ, ASİM; Bakhshaliyev, Nijad; İsmailoğlu, Ziya; Nadir, Aydın; ÖZDEMİR, RAMAZAN; BACAKSIZ, AHMET; KAHRAMAN AY, NURAY; ULUGANYAN, MAHMUT; ÇELİKKALE, İLKE; YAMAÇ, AYLİN HATİCE; ENHOŞ, ASIM; ÖZDEMİR, RAMAZAN; BACAKSIZ, AHMET; KAHRAMAN AY, NURAYPublication Open Access Utility of the Neutrophil to Lymphocyte Ratio in Predicting In-hospital Mortality in Patients That Received Levosimendan Treatment for Acute Decompensated Heart Failure(2013-10-01T00:00:00Z) Tasal, Abdurrahman; Surgit, Ozgur; BACAKSIZ, AHMET; Goktekin, Omer; Uyarel, Huseyin; Ergelen, Mehmet; Erdogan, Ercan; Kul, Seref; Sonmez, Osman; Turfan, Murat; Kucukbuzcu, Sitki; Vatankulu, Mehmet Akif; YAMAÇ, AYLİN HATİCE; BACAKSIZ, AHMET; YAMAÇ, AYLİN HATİCEAim The aim of the study was to investigate the effect of levosimendan infusion on hematological variables in patients with acute heart failure. Also, predictive value of these variables over in hospital mortality evaluated. Methods Two hundred and nineteen patients (168 male, 51 female, mean age 63.2±12.7 years) with acute exerbation of advanced heart failure (ejection fraction ≤35%) were included in this study. Levosimendan was initiated as a bolus of 6 μg/kg followed by a continuous infusion of 0,1 μg/kg/min for 24 hours. Changes of hematological variables between admission and on third day after levosimendan infusion were evaluated. Categorical variables were expressed as frequencies and percentages. Continuous variables were compared using analysis of variance and Kruskal-Wallis tests for those with normal and skewed distributions, respectively. Chi-square tests were used to compare categorical variables. Univariate and multivariate Cox regression models were used to evaluate the independent association of different hematological variables with in-hospital mortality. Results Table 1 demonstrated the baseline demographical and laboratory characteristics of the patients. After levosimendan therapy, significant decrease in WBC and neutrophil counts and increase in lymphocyte count. As a result, neutrophil to lymphocyte ratio (NLR) decreased. Compared to patients that survived, in patients who died during in-hospital stay, these hematological changes not occurred ( Table 2 ). Δ NLR detected as independent predictor of in hospital mortality when other hematological variables associated with mortality analysed in the multivariate logistic regression analysis (R2=0.094, p=0.003). Conclusion Our study showed that levosimendan treatment is associated with significant changes in hematological variables in patients with acute exacerbation of advanced heart failure. The difference between baseline and post-treatment NLR is independent predictor of in hospital mortality.Publication Metadata only Transient complete atrioventricular block associated with ticagrelor therapy after acute coronary syndrome...(2017-10-08T00:00:00Z) ENHOŞ, ASIM; ÇELİKKALE, İLKE; HUYUT, MUSTAFA AHMET; karaçöp, erdem; bakshaliyev, nijad; ULUGANYAN, MAHMUT; YAMAÇ, AYLİN HATİCE; KAHRAMAN AY, NURAY; ismayiloğlu, ziya; ÖZDEMİR, RAMAZAN; ENHOŞ, ASIM; ÇELİKKALE, İLKE; ULUGANYAN, MAHMUT; YAMAÇ, AYLİN HATİCE; KAHRAMAN AY, NURAY; ÖZDEMİR, RAMAZANPublication Metadata only EuroSCORE II and STS score as a predictor of acute kidney injury following transcatheter aortic valve replacement: two birds with one stone?(2020-12-06T00:00:00Z) BAKSHALİYEV, NİJAD; KARAÇÖP, ERDEM; ENHOŞ, ASİM; YAMAÇ, AYLİN HATİCE; KAHRAMAN AY, NURAY; ÖZDEMİR, RAMAZAN; KARAÇÖP, ERDEM; ENHOŞ, ASIM; YAMAÇ, AYLİN HATİCE; KAHRAMAN AY, NURAY; ÖZDEMİR, RAMAZAN